Check out your Company Bowl for anonymous work chats.
We’re celebrating six consecutive quarters of organic constant currency revenue growth and continued acceleration across our global portfolio. With six potential blockbuster products launched, we're on track to generate $640–720M in innovation revenue in 2025. Our Q4 and full-year 2024 results showcase the strength of our diversified business and innovation-driven strategy.
Scratching, rubbing, chewing, licking. All signs of an irritated, itchy dog. Today, Elanco Animal Health Incorporated (NYSE: ELAN), is introducing some of the first allergic dogs who have found zen and gotten back to normal by using Zenrelia. Zenrelia, which was approved by the U.S. Food and Drug Administration (FDA) and launched in September 2024, is a highly effective, convenient and safe once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest Parasite Protection of Its Kind. Credelio Quattro is the first and only monthly chewable tablet of its kind to protect against six different types of parasites, including three risky intestinal worms that can be passed to humans.
At Elanco, we believe that a healthy world starts with healthy animals. Our commitment to animal health extends beyond providing safe and effective products. It also involves nurturing the next generation of researchers and scientists who will drive the future of animal health. That's why we have established the Elanco Scholars Program, which links individuals within our talent programs as interns, post-doctoral scientists, and Fellows with additional training, networking and career development opportunities.
25,000. That’s how many hours our global team has committed to volunteering by 2025. Last year, our team recorded more than 23,600 volunteer hours supporting causes to improve animal welfare, community services, food security and education worldwide. But that’s just the start. Officially one month out from our annual Global Day of Purpose- an event to kick off a month of giving and volunteerism- our team is gearing up to make this year our biggest yet! hashtag#WeAreElanco hashtag#GDOP2024
We believe in building upon our rich history to shape a brighter future. Our Clinton, Indiana facility is at the forefront of this vision with the launch of our new “Earn to Learn” manufacturing program. For more than 50 years, our site has been a hub of innovation and community connection, a place where generations of families thrive in their joint mission with Elanco to provide food and companionship enriching life We’re excited to invite you to be part of this legacy! Our “Earn to Learn” program is a unique opportunity for you to advance your career while making a real impact. Through a partnership with Ivy Tech Community College, participants can earn full-time wages while working towards a Technical Certificate in the mechanical field. This program is designed to equip students with valuable skills and hands-on experience, all while contributing to an enterprise of purpose-driven people who believe healthy animals are the key to solving some of the world's most pressing issues. Community is at the heart of our business inside and out. Our people count on each other both at work and at home. We also believe in giving back to the community. For instance, our Clinton facility recently contributed to the Terre Haute Humane Shelter to help build a low-cost vet clinic. Together, we can build a brighter future!
We're continually striving to engage with a variety of industry groups and organizations to further drive and support diversity, equity and inclusion with a culture that fosters a sense of belonging and brings our inclusive culture to life. Our Elanco Innovation and Alliance Center (IAC) in India was recently awarded with six company awards and one individual award at the AcellHerate and DivHERsity Awards 2024, the largest DE&I summit in India that has more than 350 companies participating. The IAC team was awarded as a “Top 5 Company in divHERsity” along with being recognized among the “Top 20 Most Innovative Practices” in five categories: DivHERsity Policies, Women Returnee Programs, Women L&D Programs, Women Leadership Development and DivHERsity Programs. Also recognized was Mukta Arora for an individual award as a “Top 5 Diversity Champion”.
Two of our team members, Amanda Kephart, Executive Director of U.S. Customer Experience and Brianna Brown, Global DE&I Recruiting Strategy Leader, have been selected as part of 2023 Seramount Working Parents. This recognition is a testament to Elanco's commitment to creating an environment that supports and empowers parents to thrive both personally and professionally. We would like to extend our heartfelt congratulations to Amanda and Brianna for their well-deserved recognition.
We are dedicated to transforming animal care through science. “I’m really excited about the next era of Elanco’s innovation,” says Dr. Jennifer Miller, veterinarian technical marketer, about our canine parvovirus treatment and bringing other innovative solutions to pet owners and to pets. Check out the AgriNovus Indiana Agbioscience Podcast with Dr. Jennifer Miller below.
Today we reported our third quarter 2023 financial results, exceeding expectations. We grew revenue, adjusted EBITDA and adjusted EPS in the quarter, and begin of a trajectory of revenue growth we expect to continue in Q4 and in 2024. Our success will be driven by our differentiated global omnichannel approach, leveraging the strength of our diverse portfolio, and enhanced leadership capabilities.
